# DNA Repair and Genetic Susceptibility to Lung Cancer

> **NCT00611598** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 218 (actual)

## Conditions studied

- Lung Cancer
- Single Primary Lung Cancer
- Second Primary Lung Cancer

## Interventions

- **OTHER:** Blood draw and Questionnaires
- **OTHER:** Blood draw and Questionnaires

## Key facts

- **NCT ID:** NCT00611598
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02-11
- **Primary completion:** 2023-03-24
- **Final completion:** 2023-03-24
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611598, "DNA Repair and Genetic Susceptibility to Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00611598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*